Related Experiment Video
Updated: Jul 3, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Advances in sedation for critically ill patients.
A Morandi1, P L Watson, M Trabucchi
1Center for Health Services Research, Vanderbilt Medical Center, Nashville, TN 37232-8300, USA.
Deep sedation is no longer the standard for mechanically ventilated patients. Combining spontaneous awakening trials (SATs) with spontaneous breathing trials (SBTs) improves patient outcomes and reduces mortality.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Pharmacology
Background:
- Deep sedation was historically standard for mechanically ventilated patients to ensure comfort and prevent anxiety.
- Recent research emphasizes the importance of sedation assessment tools for guiding sedative dosing and measuring clinical response.
- Traditional deep sedation management may lead to prolonged ventilation and ICU stays.
Purpose of the Study:
- To review advancements in sedation management for mechanically ventilated patients in the ICU.
- To highlight the benefits of integrating spontaneous awakening trials (SATs) with spontaneous breathing trials (SBTs).
- To discuss emerging sedative agents and their potential impact on patient care.
Main Methods:
- Review of recent clinical trials and research in sedation management.
- Analysis of the 'wake up and breathe' approach, combining SATs and SBTs.
- Exploration of new sedative options like alpha-2 agonists and ultra-short acting narcotics.
Main Results:
- The 'wake up and breathe' approach (SATs + SBTs) significantly reduces mechanical ventilation duration by 3 days.
- This integrated strategy decreases ICU and hospital stays by 4 days.
- A notable 14% absolute reduction in one-year mortality has been observed with these combined interventions.
Conclusions:
- Integrating SATs with SBTs offers substantial clinical benefits for mechanically ventilated ICU patients.
- This approach improves patient comfort while reducing ventilation time, length of stay, and mortality.
- Novel sedative agents are under investigation to further optimize sedation management in critically ill patients.
Related Concept Videos
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...